This study tests whether low-dose aspirin can help prevent colorectal cancer from coming back in patients whose tumors have certain genetic changes (in the PI3K pathway). Over 600 patients who had surgery for stage II or III colon or rectal cancer are randomly assigned to take as…
Phase: PHASE3 • Sponsor: Anna Martling • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC